GlassScriptPhysician profile
Paul J Dougherty
NPI 1083744775
$5,767.22
in general payments reported to CMS, 2019-2025
19 companies · $2,827 in 2025
The $2,827 reported for 2025 was more than what 91% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $756 · 2020: $291 · 2021: $207 · 2022: $966 · 2023: $476 · 2024: $243 · 2025: $2,827.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,800 · Food and Beverage: $1,698 · Honoraria: $32.44 · Entertainment: $16.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,800.00 |
| Food and Beverage | $1,697.61 |
| Honoraria | $32.44 |
| Entertainment | $16.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lensar, INC. | $2,497.15 | 2025 | Lensar Laser System |
| Glaukos Corporation | $529.87 | 2019-2025 | Idosetr |
| Alcon Vision LLC | $459.58 | 2019-2025 | Clareon, Clareon Panoptix Pro, Argos |
| Staar Surgical Company | $335.48 | 2019 | |
| Rxsight INC | $287.37 | 2024-2025 | Rxsight Contact Lens, Light Adjustable Lens (Lal), Rxsight Injector Cartridge |
| Johnson & Johnson Vision Care, INC. | $267.67 | 2023 | Acuvue |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $262.18 | 2019-2020 | |
| New World Medical,INC. | $218.69 | 2022 | |
| Sight Sciences, INC. | $214.85 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $164.56 | 2020-2022 | |
| Galderma Laboratories, L.P. | $150.00 | 2020 | |
| Johnson & Johnson Surgical Vision, INC. | $100.36 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $100.00 | 2020-2022 | |
| Allergan, INC. | $61.19 | 2020-2022 | |
| Biotissue Holdings INC. | $39.80 | 2020-2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dompe US, INC. | $33.83 | 2022 | |
| Optos, INC. | $16.89 | 2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Boston Scientific Corporation | $14.59 | 2022 | |
| Abb Con-Cise Optical Group LLC | $13.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Dougherty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.